Henslee, A.B. and Steele, T.A. (2018). Combination Statin and Chemotherapy Inhibits Proliferation and Cytotoxicity of an Aggressive Natural Killer Cell Leukemia. Biomarker Res. 6: 26, doi: 10.1186/s40364-018-0140-0.
Crosbie J., Magnussen M., Dornbier R., Iannone A., Steele, T.A. (2013) Statins Inhibit Proliferation and Cytotoxicity of a Human Leukemic Natural Killer Cell Line. Biomarker Res. 1: 33-40.
Steele, T.A. and Hauser, C.C. Role of Interferon-α in a successful murine tumor therapy. Exp. Biol. Med. 230: 487-493., 2005
Young H.E., Duplaa C., Yost M.J., Henson N.L., Floyd J.A., Detmer K., Thompson A.J., Powell S.W., Gamblin T.C., Kizziah K., Holland B.J., Boev A., Van De Water J.M., Godbee D.C., Jackson S., Rimando M., Edwards C.R., Wu E., Cawley C., Edwards P.D., Macgregor A., Bozof R., Thompson T.M., Petro G.J. Jr, Shelton H.M., McCampbell B.L., Mills J.C., Flynt F.L., Steele T.A., et al. Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anatomical Record 277A: 178-203., 2004
Young H.E., Duplaa C., Romero-Ramos M., Chesselet M.F., Vourc’h P., Yost M.J., Ericson K., Terracio L., Asahara T., Masuda H., Tamura-Ninomiya S., Detmer K., Bray R.A., Steele T.A., et al. Adult reserve pluripotent stem cells and their potential for tissue engineering. Cell Biochem. Biophys. 40: 1-80., 2004
Shackelford, R.E., Mansuszak, R.P., Johnson, C.D., Hellrung, D.J., Steele, T.A., Link, C.J., and Wang, S. Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells. DNA Repair 2: 971-981., 2003
Steele, T.A. Clinical significance of interleukin-18. Leuk. Res. 26: 975-976., 2002
Steele, T.A. Chemotherapy-induced immunosuppression and reconstitution of immune function. Leuk. Res. 26: 107-110., 2002
Mawson, T. and Steele, T.A. Possible role of retinoids in hepatitis B virus-associated liver damage. Exp. Biol. Med. 226: 734-739., 2001
Young, H.E., Steele, T.A., Bray, R.A., Hudson, J., Floyd, J.A., Hawkins, K., Thomas, K., Austin, T., Edwards, C., Cuzzourt, J., Duenzl, M., Lucas, P.A. and Black, Jr., A.C. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis from fetal, adult, and geriatric donors. Anat. Record 264: 51-62., 2001
Steele, T.A. and Carpenter, S.S. Immunotherapeutic strategies for ovarian cancer. Mod. Asp. Immunobiol. 1: 131-135., 2000
K. Detmer, A.N. Walker, T.M. Jenkins, T.A. Steele and H. Dannawi. Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of Hedgehog signaling. Blood Cells, Molecules, and Diseases. Blood Cells Mol. Dis. 26: 360-372., 2000
Steele, T.A. Recent developments in the virus therapy of cancer. Proc. Soc. Exp. Biol. Med. 223: 118-127., 2000
Detmer, K., Steele, T.A., Shoop, M., Dannawi, H. Lineage-restricted expression of the bone morphogenetic protein-7 and placental bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol. Dis. 25: 310-323., 1999
Young, H. E., Steele, T.A., Bray, R. A., Detmer, K., Blake, L. W., Lucas, P. A., and Black, Jr, A. C. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56 and MHC class-I. Proc. Soc. Exp. Biol. Med. 221: 63-71., 1999
Steele, T.A. and Cox, D. C. Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response. Proc. Soc. Exper. Biol. Med. 212: 63-68., 1996
Al-Sheboul, S., Crosely, D. and Steele, T.A. Inhibition of reovirus-stimulated murine natural killer cell cytotoxicity by cyclosporine. Life Sci. 59: 1675-1682., 1996
Steele, T.A. and Cox, D. C Reovirus type 3 chemoimmunotherapy of murine lymphoma is abrogated by cyclosporine. Cancer Biother. 10: 307-315., 1995
Steele, T.A. and Brahmi, Z. Phosphatidylinositol metabolism in tumor target cell-stimulated human natural killer cells. In: Natural Killer Cells and Host Defense (E. W. Ades and C. Lopez, ed.) p. 167-171. S. Karger Publishers, Inc., New York., 1989
Steele, T.A. and Brahmi, Z. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7) is an early but postbinding event. J. Immunol. 141: 3164-3169., 1988
Steele, T.A. and Brahmi, Z. Phosphatidylinositol metabolism accompanies early activation events in tumor target cell-stimulated human natural killer cells. Cell. Immunol. 112: 402-413., 1988
Steele, T.A. and Brahmi, Z. Chlorpromazine inhibits human natural killer cell activity and antibody-dependent cell-mediated cytotoxicity. Biochem. Biophys. Res. Comm. 155: 597-602., 1988